{"id":"NCT04668157","sponsor":"Takeda","briefTitle":"A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure","officialTitle":"A Phase 3, Open-label, Multicenter, Long-term Study to Evaluate the Safety, Efficacy and Pharmacokinetics of TAK-536 in Pediatric Subjects From 2 to Less Than 6 Years of Age With Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-17","primaryCompletion":"2023-12-28","completion":"2023-12-28","firstPosted":"2020-12-16","resultsPosted":"2024-12-09","lastUpdate":"2024-12-09"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"TAK-536","otherNames":[]}],"arms":[{"label":"TAK-536","type":"EXPERIMENTAL"}],"summary":"The main aim of this study is to check the safety of TAK-536. This study will take place in Japan. At the first visit, the study doctor will check if each child can take part. For those who can take part, each participant will have a check-up by the study doctor. After this, each participant will take placebo. This might take 2 weeks.\n\nAfter this, parents or the caregivers of each participant will be given sachets that contain granules of TAK-536 to give to that participant. The participants will take the TAK-536 granules once a day for 52 weeks.\n\nAfter treatment has finished, participants will visit the study clinic for a final check-up.","primaryOutcome":{"measure":"Number of Participants Who Experienced At Least One Treatment-Emergent Adverse Event (TEAE)","timeFrame":"From first dose of study drug up to end of follow-up period (Week 54)","effectByArm":[{"arm":"Treatment Period: TAK-536 0.1 mg/kg - 0.8 mg/kg","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":19,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://clinicaltrials.takeda.com/study-detail/5fd8c7110faaff002927fb7a"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Nasopharyngitis","Pyrexia","Bronchitis","Gastroenteritis","Stomatitis"]}}